Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2151645014 | Galantamine 4mg/mL s/f oral solution (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 2159403016 | Galantamine 4mg/mL s/f oral solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galantamine 4mg/mL s/f oral solution | Is a | Product containing galantamine | false | Inferred relationship | Existential restriction modifier | ||
| Galantamine 4mg/mL s/f oral solution | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
| Galantamine 4mg/mL s/f oral solution | Has active ingredient | Galantamine | false | Inferred relationship | Existential restriction modifier | ||
| Galantamine 4mg/mL s/f oral solution | Has manufactured dose form | Conventional release oral solution | false | Inferred relationship | Existential restriction modifier | ||
| Galantamine 4mg/mL s/f oral solution | Has active ingredient | Galantamine hydrobromide | false | Inferred relationship | Existential restriction modifier | ||
| Galantamine 4mg/mL s/f oral solution | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR